BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2434359)

  • 1. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.
    Striessnig J; Knaus HG; Grabner M; Moosburger K; Seitz W; Lietz H; Glossmann H
    FEBS Lett; 1987 Feb; 212(2):247-53. PubMed ID: 2434359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.
    Vaghy PL; Striessnig J; Miwa K; Knaus HG; Itagaki K; McKenna E; Glossmann H; Schwartz A
    J Biol Chem; 1987 Oct; 262(29):14337-42. PubMed ID: 2443504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between calcium channel ligands and calcium channels.
    Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
    Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels.
    Striessnig J; Glossmann H; Catterall WA
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9108-12. PubMed ID: 2174553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.
    Striessnig J; Moosburger K; Goll A; Ferry DR; Glossmann H
    Eur J Biochem; 1986 Dec; 161(3):603-9. PubMed ID: 2431906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoaffinity labelling of Ca2+ channels with [3H]azidopine.
    Ferry DR; Rombush M; Goll A; Glossmann H
    FEBS Lett; 1984 Apr; 169(1):112-8. PubMed ID: 6325234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity labeling of the purified skeletal muscle calcium antagonist receptor by a novel benzothiazepine, [3H]azidobutyryl diltiazem.
    Naito K; McKenna E; Schwartz A; Vaghy PL
    J Biol Chem; 1989 Dec; 264(35):21211-4. PubMed ID: 2556399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
    Ferry DR; Goll A; Glossmann H
    Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
    J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.
    Sieber M; Nastainczyk W; Zubor V; Wernet W; Hofmann F
    Eur J Biochem; 1987 Aug; 167(1):117-22. PubMed ID: 2441986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit skeletal muscle microsomes contain two distinct phenylalkylamine-binding sites.
    Wernet W; Sieber M; Landgraf W; Hofmann F
    Eur J Biochem; 1988 Feb; 172(1):233-8. PubMed ID: 2450023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labelling and phosphorylation of a 165 kilodalton peptide associated with dihydropyridine and phenylalkylamine-sensitive calcium channels.
    Hosey MM; Barhanin J; Schmid A; Vandaele S; Ptasienski J; O'Callahan C; Cooper C; Lazdunski M
    Biochem Biophys Res Commun; 1987 Sep; 147(3):1137-45. PubMed ID: 2444223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazipine, a novel photoaffinity probe for dihydropyridine receptors of calcium channels.
    Taki M; Nakayama H; Kanaoka Y
    FEBS Lett; 1991 Jun; 283(2):259-62. PubMed ID: 1646123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.
    Grassegger A; Striessnig J; Weiler M; Knaus HG; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):752-9. PubMed ID: 2561307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and affinity labeling of very high affinity binding sites for the phenylalkylamine series of Ca+ channel blockers in the Drosophila nervous system.
    Pauron D; Qar J; Barhanin J; Fournier D; Cuany A; Pralavorio M; Berge JB; Lazdunski M
    Biochemistry; 1987 Oct; 26(20):6311-5. PubMed ID: 2827725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil.
    Goll A; Ferry DR; Glossmann H
    Eur J Biochem; 1984 May; 141(1):177-86. PubMed ID: 6327306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the partially purified mitochondrial phenylalkylamine calcium antagonist receptor.
    Zernig G
    Mol Pharmacol; 1992 Dec; 42(6):1010-3. PubMed ID: 1336110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.